drugset / Trial / NCT00496509
Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer
RandomizedSingle-groupOpen-labelTreatment
Summary
A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients with Advanced Colorectal Cancer and Liver Metastases.
Timeline
- Start
- 2006-08
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vandetanib | Small molecule | 100 mg | — |
| Subject | Vandetanib | Small molecule | 300 mg | — |